KCNQ2 Portal alpha (last updated 26th, February, 2026)

KCNQ2-Related Disorders: Clinical Overview

KCNQ2-related disorders encompass a spectrum of neonatal-onset epileptic and developmental phenotypes. At the mild end is self-limited familial neonatal epilepsy (SLFNE) , while at the severe end is KCNQ2-related neonatal onset developmental and epileptic encephalopathy (KCNQ2-DEE) . Increasing evidence suggests that clinical presentation is partly determined by the functional effect of the variant, with both loss-of-function (LoF) and gain-of-function (GoF) mechanisms recognized.

SLFNE typically begins with seizures at 2–8 days of life after a brief seizure-free period and remits spontaneously within the first year. Neurodevelopment and EEG outcomes are generally normal. Seizures are usually focal tonic, sometimes with clonic evolution, and about 30% later develop febrile, focal, or generalized seizures.

KCNQ2 neonatal-onset DEE KCNQ2 neonatal-onset developmental and epileptic encephalopahty (KCNQ2-DEE) is most commonly caused by LoF variants. However, GoF variants are now recognized as an important and distinct disease mechanism that can produce overlaping but clinically different presentations.

Loss-of-Function (LoF)–Associated Phenotype: Typically presents within the first days of life with frequent focal tonic seizures, often with apnea and oxygen desaturation. Seizures are usually reftractory and associated with encephalopathy , abnormal interictal EEG with burst-suppression , and transient MRI changes in the basals ganglia or thalamus . Affected infants show profound developmental impairment with hypotonia, severe motor and speech disability. Although seizure frequency often decreases over time, many individuals continue to require long-term supporive care.

Gain-of-Function (GoF)-Associated Phenotype: Gain-of-function KCNQ2 variants have been increasingly recognized in patients presenting with neonatal encephalopathy accompanied by severe developmental impairment and hypotonia. Movement abnormalities, such as non-epileptic myoclonus or dyskinesia, can be prominent features. Epilepsy may be less prominent or may develop later during infancy, and in some individuals, the degree of developmental impairment appears greater than expected based on seizure severity.

KCNQ2 Genotype to Phenotype

KCNQ2-related conditions occur when a brain channel that normally helps regulate neuronal excitability does not function properly. If the channel is underactive, affected individuals may experience seizures shortly after birth, which can range from mild to severe. If the channel is overactive, neonatal seizures typically do not occur, but developmental challenges may emerge later in childhood. These can include cognitive delays, impairments in language or motor function, or, in some cases, autism spectrum disorder.

For further details, see:

• GeneReviews: KCNQ2-Related Disorders
• Cambridge: KCNQ2- and KCNQ3-Associated Epilepsy

Clinical Summary of KCNQ2-related Disorders